People taking GLP-1 drugs have a low risk of hair loss, which is significantly higher than for those on other diabetes ...
Johnson & Johnson has unveiled massive phase 3 survival data for its dual bispecific combination in earlier-line multiple ...
Opinion
6hon MSNOpinion
Testosterone testing the military: how the manosphere shaped US government policy
The United States Secretary of War Pete Hegseth has ordered all active duty and reserve personnel aged 30 and over be screened for testosterone deficiency as part of their periodic health assessment.
Morning Overview on MSN
GLP-1 weight-loss shots were tied to a 30% drop in breast cancer across 110,000 women
Women taking GLP-1 receptor agonist drugs such as semaglutide for weight loss showed roughly 30 percent lower breast cancer ...
Labor will respond to growing anxiety about the rise of artificial intelligence with a new taskforce to give Australian ...
Here's how to register teams for the pickleball tournament, Picklepalooza, a fundraiser for the WNC Food Coalition on Aug. 14 ...
Morning Overview on MSN
Pushing blood pressure below 120 cut heart attacks and strokes for diabetics by a fifth
Adults with type 2 diabetes and elevated cardiovascular risk who had their systolic blood pressure driven below 120 mm Hg ...
Hearing aids may reduce dementia risk in people with hearing loss. For the first time, the World Health Organization (WHO) is ...
Eli Lilly and Company , the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-2 and TRIUMPH-3, two pivotal Phase 3 trials evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results